Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 2009

View Archived Issues

Levodopa/carbidopa duodenal infusion improves psychiatric symptoms in Parkinson's disease patients

Roche discovers farnesoid X receptor agonists for the treatment of lipoprotein disorders

Botulinum toxin type A significantly improves major subtypes of cervical dystonia

Eculizumab appears to reduce the risk of acute humoral rejection in kidney transplant recipients

Roche presents Bruton's tyrosine kinase inhibitors for the treatment of rheumatoid arthritis

Jimro claims novel CXCL10 production inhibitors

K-858 shows promising preclinical antitumor effects by specifically inducing tumor cell death

PolyMedix receives grant to support development of heptagonists

UPCI joins Gamida Cell's phase II ExCell study of StemEx in leukemia and lymphoma

Boehringer Ingelheim discovers ICAM-1 and LFA-1 interaction inhibitors for the treatment of asthma

Astellas discovers NMDA receptor antagonists for the treatment of Alzheimer's disease

ADX-10059 improves clinical GERD symptoms; data from a first-in-man study disclosed

Novel tryptophan hydrolase inhibitor LX-1031 under clinical development for irritable bowel syndrome

Synta and GSK to end collaborative agreement for elesclomol by September 2009

Boehringer and Vitae sign collaboration agreement to develop BACE inhibitors in AD

Thevac and undisclosed pharmaceutical company initiate testing of NanoViricides' eye drug

Axis-Shield and Hansa sign global agreement for exclusive rights to sepsis diagnostic assay

FDA accepts for filing and review OSI's sNDA for Tarceva in NSCLC

PTC receives two U.S. government grants to support development of PTC-299 and ataluren

Lilly initiates PD2 drug discovery initiative in Alzheimer's, cancer, diabetes and osteoporosis

Dr. Reddy's and GSK sign strategic alliance for emerging markets outside India

Adventrx sells shares to fund activities related to seeking FDA approval for vinorelbine

Celgene reports preliminary results from phase II study of apremilast in psoriatic arthritis

Alexza exercises option to purchase all of the equity of Symphony Allegro

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...